) and specific symptoms (loss of smell or taste and stroke) were described (91, 113–115). Epidemiological studies have reported that some patients infected with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascul